News
Curated Newsfeed
-
Cleantech startups validate their technologies on land and water
Restor has launched a project with Guatemala government to monitor over half a million hectares and 83,000 sites by 2030 while Neustark launched its first…
startupticker.ch
-
CHF 1.5 billion for Swiss start-ups – high-flyers ensure good numbers
CHF 1.47 billion in venture capital went to Swiss start-ups in the first half of 2025, the third best result ever. A small handful of…
startupticker.ch
-
CHF 79 million to advance Nuclidium’s copper-based radiopharmaceutical platform
NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, has closed its Series B financing round led by Kurma Growth Opportunities Fund.…
startupticker.ch
DTN Highlights
-
Read more: From Momentum to Mission: What the Latest VC-Trends Mean for Deep Tech in Switzerland
This mid-year reading of startupticker.ch and SECA’s Swiss VC Report takes the surface rebound—a healthy rise in invested capital—and weighs it against quieter signals: fewer…
-
Read more: Globally Unique Focus on Deep Tech
The first Swiss Deep Tech Report presents data-driven evidence of the advantages that make Switzerland a global deep tech hotspot. It also provides an in-depth…
-
Read more: Deep Tech Nation CEO in Le Temps: “If We Want Economic Giants, We Must Wake Up”
Our CEO, Joanne Sieber, recently sat down with the influential Swiss newspaper Le Temps to discuss a critical challenge for the nation’s future: financing the…
-
Veraxa plans to go public via SPAC at $1.64 billion valuation
Xlife Sciences’ portfolio company VERAXA Biotech AG, a biopharmaceutical company focused on next-generation cancer therapies, and Voyager Acquisition Corp., a special purpose acquisition company listed…
startupticker.ch
-
novoMOF raises CHF 4.4 million to scale CO2-capture materials
GTT Strategic Ventures, the investment fund of the GTT group, has completed a CHF 4.4 million funding round in novoMOF, a specialist in advanced materials for…
startupticker.ch
-
Cellestia Biotech spins-off Anciata Therapeutics
The newly formed U.S.-based Anciata Therapeutics aims to develop to clinical proof of concept for a first-in-class therapeutic candidate with the potential to treat certain…
startupticker.ch
-
Following a CHF 4 million seed round, Rekord AG closes two strategic deals
Through its platform, Zug-based Rekord AG, enables any system, sensor, or software to anchor data on-chain for later verification, ensuring a single source of truth.…
startupticker.ch
-
Swisspod’s expands US presence with a manufacturing and assembly facility
With the expansion into Colorado Springs, Swisspod, a manufacturer of high-speed vehicles and subsystems for transportation assets, will create over 100 new jobs while advancing…
startupticker.ch
-
CelsiusPro acquires London-based Disaster Risk Finance team
With the hiring of a world-class Disaster Risk Finance team from the WTW Climate and Resilience Hub, CelsiusPro has strengthened its Climate Resilience Solutions. The…
startupticker.ch
-
Avoiding tariffs with a U.S. production partner
For INVOLI outsourcing manufacturing has always been part of the strategy. As a result, the Swiss leading provider of hardware and software solutions for the detection…
startupticker.ch
-
Loft Dynamics secures funding to develop Boeing 737 VR simulators
Alaska Airlines, through its corporate venture capital arm, has invested in Loft Dynamics — an industry leader in virtual flight training and the developer of…
startupticker.ch
-
Teylor to acquire the factoring businesses of grenke AG in seven countries
Swiss fintech Teylor is acquiring grenke’s factoring division to accelerate the expansion of the Teylor Platform and further solidify its position as the leading SME…
startupticker.ch
-
Novigenix obtains EUR 1.8 million EU grant to industrialize AI-powered liquid biopsy
As part of the BRECISE IHI Consortium, Swiss startup Novigenix has been awarded EUR 1.8M funded by the European Union (EU) research initiative focusing on…
startupticker.ch
-
MoonLake Immunotherapeutics secures up to $500 Million in non-dilutive financing
Zug-based MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on inflammatory diseases, has secured up to $500 million in non-dilutive capital. It provides funding for the…
startupticker.ch
-
Bloom Biorenewables raises CHF 13 million for market entry
Fribourg-based Bloom Biorenewables has successfully completed a CHF 13 million series A funding round. The new funding will be used over the coming years to…
startupticker.ch
-
Read more: From Momentum to Mission: What the Latest VC-Trends Mean for Deep Tech in Switzerland
This mid-year reading of startupticker.ch and SECA’s Swiss VC Report takes the surface rebound—a healthy rise in invested capital—and weighs it against quieter signals: fewer…
-
Read more: Globally Unique Focus on Deep Tech
The first Swiss Deep Tech Report presents data-driven evidence of the advantages that make Switzerland a global deep tech hotspot. It also provides an in-depth…
-
Read more: Deep Tech Nation CEO in Le Temps: “If We Want Economic Giants, We Must Wake Up”
Our CEO, Joanne Sieber, recently sat down with the influential Swiss newspaper Le Temps to discuss a critical challenge for the nation’s future: financing the…
-
Read more: Microsoft’s USD 400 Million Bet on Swiss AI
Microsoft has confirmed a four-hundred-million-dollar programme to expand its Swiss cloud and AI footprint, launch a national accelerator for startups and SMEs, and equip 100…
-
Read more: AI Pioneers in the Life Sciences Sector
Switzerland’s strong life sciences sector is a pace setter in combining traditional approaches from the pharma and medtech industries with AI. Several start-ups have recently…
-
Read more: Swiss AI Enters a New Era: inait SA and the Rise of Digital Brains
Swiss AI startup inait is redefining artificial intelligence by building digital brains—software systems that simulate human reasoning. Backed by Microsoft and rooted in neuroscience from…
-
Read more: CUTISS: A Swiss Techbio Champion Ready to Lead the Global Health Revolution
CUTISS is reshaping the future of skin surgery with denovoSkin™, a groundbreaking techbio innovation born in Switzerland. As it nears global commercialization, CUTISS highlights both…
-
Read more: Success Story: Péter Fankhauser
ANYbotics’ Péter Fankhauser takes on Boston Dynamics with robot dogs built for dangerous inspections—backed by $60M and global clients.
-
Read more: Millions for Research but no Money for Growth: Swiss Startups are Looking Abroad for Investors
Translated from NZZ, this article explores why Swiss startups often seek growth capital abroad despite strong local innovation roots.
-
Read more: How Swiss Startups are Making Their Mark on Agentic AI
Discover how Swiss startups are leading the crowded agentic AI space with cutting-edge, goal-driven AI agents tailored for finance, law, gaming, and software—powered by scientific…
-
Read more: Swiss Deep Tech Venture Capital: The 2025 EU Deep Tech Report
Europe’s deep tech ecosystem has become a potent driver of innovation, standing strong despite broader venture capital market fluctuations. Switzerland is gaining recognition as a…
-
Read more: What Can We Learn From W.A. De Vigier Awards 2025 Finalists
Discover insights about the Swiss Innovation ecosystem through an analysis of the W.A. De Vigier Startup Funding Competition Finalists